CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Diamond Biotechnology Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Diamond Biotechnology Co Ltd
11F, No. 45, Section 2
Fuxing South Road, Da'an District
Phone: +886 227553320p:+886 227553320 TAIPEI, 106  Taiwan Ticker: 68156815
Business Summary
Diamond Biotechnology Co Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of skin care products and medical equipment. The main products are skin care products and medical equipment. The skin care products include facial masks, lotions, creams, essences and others, which are mainly used for facial skin care and cleaning. The medical equipment includes wires, sonic wave medical equipment, radio wave medical equipment, frozen fat reduction medical equipment and other medical equipment, as well as micro plastic surgery consumables such as botulinum and collagen injections, which are mainly used to improve skin wrinkles and sagging. The Company is also engaged in the provision of medical equipment leasing services and medical beauty management consulting services. The Company operates within the domestic market and to overseas markets.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus
3842 Orthopedic, prosthetic, and surgical appliances and supplies
2844 Perfumes, cosmetics, and other toilet preparations
7359 Equipment rental and leasing, not elsewhere classified
8742 Management consulting services

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Brand Officer BoruLai 5/24/2019 11/26/2014
Chief Financial Officer, Executive Deputy General Manager, Corporate Governance Officer XiangqiHuang 11/15/2024 3/22/2024
General Manager, Chief Research & Development Officer, Director JiaxianXie 1/1/2019 11/26/2014
6 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 33,794,551 (As of 9/11/2024)
Stock Exchange: TPO
Fax Number: +886 227553326


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024